InvestorsHub Logo
Followers 33
Posts 5288
Boards Moderated 0
Alias Born 01/23/2019

Re: Biobillionair post# 290029

Wednesday, 08/05/2020 7:04:16 PM

Wednesday, August 05, 2020 7:04:16 PM

Post# of 425842
BB, I agree that AMRN has made some questionable statements that don't jive with public information. Such as generics are incapable of launching GV depending on the outcome of an appeal. I totally recall that at the Nov 2019 AHA conference someone from this board was in attendance and mentioned that Hikma or it's third party supplier presented a slide deck with GV projected sales of $750 million in domestics sales for GV. Raf doesn't recall but somewhere in the archives there's a clip of Hikma available I haven't located yet but will eventually.
I respect all your efforts and am all for going after all resources to try and force AMRN to come clean. But at this juncture it's not happening, at the risk of some self disclosure I have extensive background in all facets of the stock market. Amarin will not and should never disclose private talks with potential buyers.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News